What is McCreadie Group?
McCreadie Group is a specialized provider of innovative software solutions designed to optimize clinical trials and enhance pharmacy education. Its core offering, Vestigo, is a robust site-enablement platform tailored for clinical research sites, academic medical centers, and sponsors. Vestigo is engineered to boost operational efficiency and ensure stringent compliance within investigational drug operations and residency program management. The company serves a broad spectrum of users, including pharmacy and clinical research teams, clinical research associates, and executive administration, all seeking to refine their operational workflows. McCreadie Group is committed to delivering reliability and comprehensive support, aiming to revolutionize how clinical research and pharmacy education programs are managed.
How much funding has McCreadie Group raised?
McCreadie Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in McCreadie Group
PPP
Public-Private Partnership
What's next for McCreadie Group?
With a substantial total funding of $350K and a recent strategic investment of $350K, McCreadie Group is well-positioned for its next phase of growth. This late-stage funding context suggests a focus on scaling operations, expanding market reach, and potentially further developing its technological infrastructure. The company's strategic capital injections will likely fuel initiatives aimed at solidifying its leadership in clinical trial software and pharmacy education solutions, potentially through market penetration, product enhancement, or strategic partnerships. The company's trajectory points towards continued innovation and market influence.
See full McCreadie Group company page
